{"columns":["outcome_ids","turner_outcome_type","pharm_vs_placebo_control","pharm_vs_pharm"],"rows":[["O20","All-cause mortality","LN(-3.95; 1.34^2)","LN(-4.18; 1.41^2)"],["O21;O21B;O22;O22B;O22C;O22D;O22E;O23;O23B;O40;O50","Cause-specific mortality/major morbidity event/composite","LN(-3.71; 1.74^2)","LN(-3.95; 1.79^2)"],["O14","Infection/onset of new acute/chronic disease","LN(-2.49; 1.52^2)","LN(-2.73; 1.58^2)"],["O26;O27E","Withdrawals/drop-outs","LN(-2.99; 1.74^2)","LN(-3.23; 1.79^2)"],["O04;O04B;O25;O27A;O27B;O27C;O27D;O28;O29;O30;O31;O32A;O32B;O33;O34;O35B;O36A;O36B;O37A;O37B;O38;O39;O121","Adverse events","LN(-1.87; 1.52^2)","LN(-2.10; 1.58^2)"],["O35A","Mental health indicators","LN(-2.12; 1.53^2)","LN(-2.35; 1.60^2)"],["O03;O60;O61","Biological markers (dichotomised)","LN(-1.77; 1.52^2)","LN(-2.00; 1.58^2)"],["O11A;O11B;O11C;O11D;O11E","General physical health indicators","LN(-2.29; 1.53^2)","LN(-2.53; 1.58^2)"],["O90A;O90B;O110B;O111;O111B;O112;O113","Signs/symptoms reflecting continuation/end of condition","LN(-2.06; 1.51^2)","LN(-2.29; 1.58^2)"],["O90C;O120","Obstetric outcomes","LN(-3.52; 1.74^2)","LN(-3.75; 1.79^2)"]]}
